Zhejiang Medicine Co.,Ltd.’s Net Profit Dropped 49.5% in First Three Quarters of 2023

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 180.9 million yuan in the first three quarters of 2023, down 49.5% year-on-year.

Meanwhile, the company posted 5.9 billion yuan in revenue, down 4% year-on-year.

At the end of the reporting period, it had 12.6 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 21.4%.